DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2002 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: ARESTIN

Summary for Tradename: ARESTIN

Patents:0
Applicants:1
NDAs:1
Suppliers: see list1
drug
patent expirations by year for
 ARESTIN

Pharmacology for Tradename: ARESTIN

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

Clinical Trials for: ARESTIN

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
Status: Recruiting Condition: Lung Cancer

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Status: Recruiting Condition: Head And Neck Cancer

Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin
Status: Terminated Condition: Acne Vulgaris

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
Status: Active, not recruiting Condition: Depressive Disorder

A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
Status: Recruiting Condition: Esophageal Cancer

Minocycline Study in Pancreatic Cancer Patients
Status: Recruiting Condition: Pancreatic Cancer

A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
Status: Active, not recruiting Condition: Lung Cancer

Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Recruiting Condition: Bipolar Disorder Depression

Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Status: Recruiting Condition: Colorectal Cancer

Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
Status: Completed Condition: Schizophrenia

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Orapharma
ARESTIN
minocycline hydrochloride
Powder, Extended Release; Dental050781FEB 16, 2001RXYes<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc